Cilinidipine 10mg + Metoprolol 25mg

CILINITAB M 25 

Metoprolol Succinate 23.75 mg & Cilnidipine 10 mg

Cilinitab M 25 is a widely used medication primarily prescribed to manage high blood pressure (hypertension) and associated cardiovascular issues. The medication combines two powerful active ingredients: Metoprolol Succinate (23.75 mg) and Cilnidipine (10 mg). Together, these components create an effective therapy that targets both the heart rate and the vascular system, helping to lower blood pressure, reduce the risk of cardiac events, and improve overall cardiovascular health.

Hypertension is a significant health concern worldwide, often referred to as a “silent killer” because of its lack of immediate symptoms but profound impact on heart health if left untreated. By controlling blood pressure, Cilinitab M 25 can prevent damage to the arteries, reduce strain on the heart, and minimize risks of heart attack, stroke, and other cardiovascular complications.

Key Features and Ingredients

1. Metoprolol Succinate (23.75 mg)

   • Type: Beta-blocker
   • Action: Metoprolol selectively blocks beta-1 adrenergic receptors, primarily in the heart. By doing so, it slows down the heart rate, reduces heart workload, and lowers blood pressure. This action decreases the amount of oxygen the heart needs, which is particularly beneficial for patients at risk of angina (chest pain) and heart attack.

2. Cilnidipine (10 mg)

   • Type: Calcium channel blocker (specifically, a dihydropyridine calcium channel blocker)
   • Action: Cilnidipine works by relaxing blood vessels, allowing blood to flow more easily. It blocks calcium entry into the cells of the blood vessels and also has an effect on the sympathetic nerves around these vessels, which helps in reducing blood pressure effectively.

3. Dual Mechanism

   • Synergy of Action: The combination of Metoprolol and Cilnidipine allows Cilinitab M 25 to target blood pressure through two different mechanisms: controlling heart rate (Metoprolol) and reducing blood vessel tension (Cilnidipine). This combined approach helps in achieving more stable and consistent blood pressure management.

Usage

Cilinitab M 25 should be used only under the guidance of a healthcare provider. Dosage and frequency depend on the patient’s individual needs, medical history, and current health status. Generally, it is taken once daily, preferably at the same time each day, to ensure consistent blood levels. It is recommended to take the medication with water, with or without food, and to avoid abruptly stopping the medication, as it can cause withdrawal symptoms.

Benefits of Cilinitab M 25

1. Efficient Blood Pressure Control

   • Cilinitab M 25 is particularly effective for patients who need comprehensive blood pressure management, addressing both systolic and diastolic pressures. This makes it suitable for those with moderate to severe hypertension.

2. Reduces Cardiovascular Risks

   • Lowering blood pressure has long-term cardiovascular benefits. By maintaining blood pressure within a healthy range, Cilinitab M 25 reduces the risk of heart disease, stroke, kidney damage, and vascular issues, protecting vital organs from the potential damage associated with high blood pressure.

3. Long-acting, Sustained Release

   • Metoprolol Succinate is an extended-release formulation that provides continuous beta-blocking effects, resulting in more stable blood pressure control over the day and reducing the risk of blood pressure spikes.

4. Reduces Sympathetic Nervous System Activation

   • Cilnidipine’s action on the sympathetic nervous system prevents sudden spikes in blood pressure often caused by stress, anxiety, or sympathetic overactivity. This feature is particularly useful for individuals who experience stress-related increases in blood pressure.

5. Minimal Side Effects

   • Thanks to the selective action of Metoprolol and Cilnidipine, Cilinitab M 25 generally has a favorable side effect profile. Patients often experience fewer adverse effects like swelling and dizziness than with other antihypertensive medications.

6. Improves Patient Compliance

   • The once-daily dosage of Cilinitab M 25 enhances patient adherence, making it easier to follow the treatment regimen and achieve better long-term health outcomes.

Conclusion

Cilinitab M 25 (Metoprolol Succinate 23.75 mg & Cilnidipine 10 mg) is an innovative and effective solution for managing hypertension. By combining the beta-blocking effects of Metoprolol with the vasodilatory properties of Cilnidipine, it provides a dual-action approach that controls blood pressure efficiently and reduces cardiovascular risks. This medication is suitable for adults with high blood pressure and those at risk for heart conditions, helping patients manage their condition and improve their quality of life. As with any medication, Cilinitab M 25 should only be taken under medical supervision, ensuring that patients receive the full benefits of this highly effective combination treatment. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488 

BUY NOW